AC Gales, RN Jones… - Journal of …, 2011 - Br Soc Antimicrob Chemo Results The polymyxins showed potent in vitro activities (MIC 90 , ≤0.5–1 mg/L) against this large collection of clinical isolates, with very low resistance rates (<0.1%–1.5%). Resistance to the polymyxins remained stable among organisms tested except for Klebsiella spp. ... Related articles - All 2 versions
Y Isa, N Harayama, H Arai, T Shinjou, K Nagata… - Critical Care, 2011 - ccforum.com From January 2007 to June 2010, 69 patients who received polymyxin B hemoperfusion therapy were retrospectively reviewed. Two child cases, six cases of 24-hour death and the seven cases in whom bacteremia was not detected by blood culture test were excluded. In total, for 54 ... Related articles - Cached - All 2 versions
C Urban, H Tiruvury, N Mariano… - Antimicrobial agents …, 2011 - Am Soc Microbiol Clinical infections due to multidrug-resistant, extremely drug-resistant, and panresistant strains of Gram-negative bacteria have been steadily increasing over the past decade (1, 2, 6, 13, 14). While strains resistant to polymyxin B and colistin (polymyxin E) have been reported ... Cited by 3 - Related articles - All 4 versions
ALH Kwa, K Abdelraouf… - Clinical Infectious …, 2011 - cid.oxfordjournals.org To our knowledge, this is the first re- port to date of the pharmacokinetics of polymyxin B in a patient with renal in- sufficiency. Polymyxin B1 is the major component of polymyxin B (USP). The serum elimination half-life of polymyxin B1 in renal insufficiency was 11.5 h, ... Related articles - All 4 versions
LA Arroyo, CM Herrera, L Fernandez… - Antimicrobial Agents …, 2011 - Am Soc Microbiol Page 1. 1 The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 1 17978 and clinical isolates through phosphoethanolamine modification of 2 ... mail: bob@cmdr.ubc.ca 15 Running title: Polymyxin-resistance in A. baumannii 16 ABSTRACT 17 ...